Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study

BACKGROUND: Application of repetitive transcranial magnetic stimulation (rTMS) for treating obsessive-compulsive disorder (OCD) has been promising and approved by the Food and Drug Administration in 2018, but effects differ between patients. Knowledge about clinical predictors of rTMS response may h...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Psychiatry
Egile Nagusiak: Rostami, Reza, Kazemi, Reza, Jabbari, Arezoo, Madani, Azam Sadat, Rostami, Hosseinreza, Taherpour, Mohammad Amin, Molavi, Parviz, Jaafari, Nematollah, Kuo, Min-Fang, Vicario, Carmelo M., Nitsche, Michael A., Salehinejad, Mohammad Ali
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364645/
https://ncbi.nlm.nih.gov/pubmed/32677923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-020-02769-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak